These ChIP-seq results identified chromosomal loci, including super-enhancers, occupied by BRD4 in an aggressive HCC cell line and perturbation of this landscape upon exposure to AZD5153, a clinically relevant BRD4 inhibitor. This evidence concerns the gene BRD4 and hepatocellular carcinoma.